HON vs ZNTL · P/E 36, rev $9.72B vs $257.7M cap
Honeywell International Inc (HON) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal M. Kapur.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
HON currently screens at market cap $144.86B and trailing P/E 36.5. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the HON and ZNTL stock pages for the full models.
Not investment advice.